Back to Search Start Over

Right bundle branch block is not associated with worse short- and mid-term outcome after transcatheter aortic valve implantation.

Authors :
Weferling M
Liebetrau C
Renker M
Fischer-Rasokat U
Choi YH
Hamm CW
Kim WK
Source :
PloS one [PLoS One] 2021 Jun 16; Vol. 16 (6), pp. e0253332. Date of Electronic Publication: 2021 Jun 16 (Print Publication: 2021).
Publication Year :
2021

Abstract

Background: Transcatheter aortic valve implantation (TAVI) is the standard treatment option for patients with severe aortic stenosis (AS) at intermediate or high surgical risk. Preexisting right bundle branch block (RBBB) is a strong predictor of new pacemaker implantation (PPM) after TAVI, and previous data indicate a worse short- and long-term outcome of patients. The aim of this study was to investigate whether preexisting RBBB has an effect on the short- and mid-term outcome of patients undergoing TAVI in a German high-volume TAVI center.<br />Methods: For the present retrospective analysis, a total of 1,891 patients with native severe AS with successful TAVI without preexisting PPM were included. The primary endpoint was all-cause mortality after 30 days and 12 months. Baseline RBBB was present in 190 (10.1%) of cases.<br />Results: Patients with preexisting RBBB had a considerably higher rate of new PPM after TAVI compared with patients without RBBB (87/190 [45.8%] vs. 219/1,701 [12.9%]; p<0.001). RBBB had no impact on all-cause mortality at 30 days (2.1% vs. 2.7%; p = 0.625) and at 12 months (14.4% vs. 13.6%; p = 0.765). Further stratification according to the presence of new PPM showed a difference in mid-term survival rates between the four groups, with the worst outcome for patients without RBBB and new PPM (log rank p = 0.024). However, no difference in mid-term cardiovascular survival was found.<br />Conclusion: Preexisting RBBB is a common finding in patients with severe AS undergoing TAVI and is associated with considerably higher PPM rates but not with worse short- and mid-term outcome.<br />Competing Interests: MR received speaker fees from Abbott, CWH contributes to the advisory board of Medtronic, and WK received proctor/speaker honoraria from Abbott, Boston Scientific, Edwards Lifesciences, and Medtronic (other authors have nothing to disclose). This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Details

Language :
English
ISSN :
1932-6203
Volume :
16
Issue :
6
Database :
MEDLINE
Journal :
PloS one
Publication Type :
Academic Journal
Accession number :
34133470
Full Text :
https://doi.org/10.1371/journal.pone.0253332